Breaking News
Ep. 1372 The Biden Scandal Explodes
US Government Publishes Enforcement Framework, $4.8 Billion Silk Road Bitcoin Missing
NOO WAY!! IMF SINGLE WORLD CURRENCY 2021!!!
Social Mediacracks down this week and it may backfire
Top Tech News
BIG shoots for the Moon with 3D-printed lunar habitat plan
Did Trump Just Legalize Psychedelics?
D-Wave Systems Releases 5000+ Qubit Quantum Annealer
China's Mars probe Tianwen-1 snaps 'selfies' on its way to the Red Planet after releasin
The President Has an 'Internet Kill Switch.' A Bipartisan Group of Lawmakers...
Ramjet Artillery and Missiles Will Have Five Times the Range
Electric air taxi could take to the Paris skies in time for the Olympics
Hyundai gets serious about unstoppable, four-legged 4x4 robo-cars
Study reveals potential of hydropower dams topped with floating solar
Gryphon Technologies to develop nuclear rocket engine for DARPA
Finally Confirmed! Vitamin D Nearly Abolishes ICU Risk in COVID-19
The First Randomized Controlled Trial on Vitamin D and COVID-19
The trial was conducted at the Reina Sofi?a University Hospital in Co?rdoba, Spain. The trial included 76 patients with COVID-19 pneumonia. Although this is no longer the standard of care, all patients were treated with hydroxychloroquine and azithromycin and, when needed, a broad-spectrum antibiotic. Admission to the ICU was determined by a multidisciplinary committee consisting of intensive care specialists, pulmonologists, internal medicine specialists, and members of the ethics committee.
The patients were randomly allocated to receive or not receive vitamin D in a 2:1 ratio. This resulted in 50 patients in the vitamin D group and 26 patients in the control group.